Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-08

Clinical Trial Update: Combining Varenicline and Bupropion for Smoking Cessation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of varenicline and bupropion for smoking cessation has completed, with results posted in July 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)
  • bupropion (bupropion)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED | Results posted: 2021-07-08